Statistics for Novel Prostate-Specific Promoter Derived from PSA and PSMA Enhancers
Total visits
views | |
---|---|
Novel Prostate-Specific Promoter Derived from PSA and PSMA Enhancers | 119 |
Total visits per month
views | |
---|---|
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
File Visits
views | |
---|---|
PIIS1525001602906829.pdf | 118 |
java.util.UUID:559a2a1a-7f98-42e8-8b12-691ed1f666ac | 66 |
java.util.UUID:5a919141-ddfa-4496-a98f-b48588f294d5 | 18 |
java.util.UUID:4cb71c25-4d3f-4419-814c-7d3cdb8cb8b6 | 9 |
Top country views
views | |
---|---|
United States | 91 |
Canada | 2 |
United Kingdom | 2 |
Australia | 1 |
China | 1 |
Czechia | 1 |
Germany | 1 |
Greece | 1 |
Malaysia | 1 |
Philippines | 1 |
Russia | 1 |
Sweden | 1 |
Taiwan | 1 |
Top city views
views | |
---|---|
Wilmington | 36 |
Fairfield | 13 |
Houston | 8 |
Lanham | 3 |
Ann Arbor | 2 |
Cambridge | 2 |
Chicago | 2 |
Jacksonville | 2 |
San Francisco | 2 |
Toronto | 2 |
Warrington | 2 |
Athens | 1 |
Baltimore | 1 |
Cleveland | 1 |
Kalkallo | 1 |
Kiez | 1 |
Kuala Lumpur | 1 |
Monmouth Junction | 1 |
Moscow | 1 |
Saint John | 1 |
Slapanice | 1 |
Stockholm | 1 |
Taipei | 1 |